HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

5th Edition of

International Ophthalmology Conference

Translational and Experimental Ophthalmology

Translational and Experimental Ophthalmology

Translational and experimental ophthalmology bridges the gap between laboratory research and clinical practice, turning scientific discoveries into practical treatments. By focusing on innovative research, this field seeks to translate basic science into real-world applications, offering new treatments for ocular diseases such as retinal degeneration, corneal disorders, and optic neuropathies. Advances in gene therapy, stem cell research, and novel drug delivery systems are among the key areas driving progress. This research is crucial for improving treatments for conditions like age-related macular degeneration, where conventional therapies often fall short. Translational efforts are not only focused on developing new therapies but also on optimizing current treatment protocols to improve patient outcomes. The ultimate goal is to improve patient care by integrating cutting-edge scientific findings into clinical practice, offering hope for individuals with conditions that were once considered untreatable.

Committee Members

Speaker at IOC 2027 - Shadrokh Nabili

Shadrokh Nabili

University Hospitals of Morecambe Bay NHS Foundation Trust, United Kingdom
Speaker at IOC 2027 - Magali Taiel

Magali Taiel

GenSight Biologics, France
Speaker at IOC 2027 - Tim Jackson

Tim Jackson

King’s College London, United Kingdom

IOC 2027 Speakers

Speaker at IOC 2027 - Abdullah Shakeel

Abdullah Shakeel

Princess Alexandra Hospital NHS Trust, United Kingdom
Speaker at IOC 2027 - Kritika

Kritika

Gupta Eye Hospital, India
Speaker at IOC 2027 - Shakeel Mohammed

Shakeel Mohammed

Sunshine Coast Hospital & Health Service, Australia
Speaker at IOC 2027 - Muallah

Muallah

Shaikh Zayed Hospital, Pakistan

Tags

Submit your abstract Today

YouTube
WhatsAppWhatsApp